Aditx Therapeutics

Executive Summary

Aditx Therapeutics is a private diagnostics company based in Newark, US, founded in 2018. The company's business model revolves around acquiring, developing, and deploying disruptive and scalable innovations positioned for growth in targeted health markets. By leveraging an evolving operational platform, Aditx aims to address pressing health challenges through a portfolio of acquired technologies. Despite its small valuation (~$411K) and early stage, the company's strategy of identifying and scaling promising innovations positions it for potential growth. Current focus remains on building its pipeline and expanding its technological footprint.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new acquisition in diagnostics or therapeutics60% success
• Q4 2026Strategic partnership with a major healthcare provider or research institution40% success
• Q1 2027FDA clearance or CE marking for a lead diagnostic platform30% success